Based on 12 reviews
I recently started using a new platform for data management, and I'm really impressed with the results. It's easy to use, and I've found it to be quite efficient. The support team is really responsive and helpful. Overall, it's been a great experience and I would recommend it to others.
I have been using Rdmd for a few months now and I must say their service is excellent. The website is user-friendly and the customer support is always responsive and helpful. The data they provide is accurate and reliable. I highly recommend Rdmd to anyone in need of data management solutions. Keep up the good work!
I have been using Rdmd for a few months now and I must say their service is excellent. The website is user-friendly and the customer support is always responsive and helpful. The data they provide is accurate and reliable. I highly recommend Rdmd to anyone in need of data management solutions. Keep up the good work!
I've tried multiple data management platforms, but Rdmd is by far the best. The platform is intuitive and user-friendly, and the customer support team is always available to assist. I appreciate the accurate and reliable data they provide. Rdmd has definitely improved my workflow!
I just started using Rdmd and I'm loving it! The interface is so user-friendly and intuitive. I can easily access and manage all my data with just a few clicks. The customer support team is also very helpful and responsive. I'm really happy with my experience so far!
I recently started using a new platform for data management, and I'm really impressed with the results. It's easy to use, and I've found it to be quite efficient. The support team is really responsive and helpful. Overall, it's been a great experience and I would recommend it to others.
I've been using Rdmd for a while now, and it has been a game-changer for my data management needs. The platform is easy to use, and the customer support team is always available to assist. I highly recommend Rdmd to anyone in need of reliable data management solutions.
I can't express how satisfied I am with Rdmd. The platform is user-friendly and efficient, and the customer support team is incredibly helpful. They have provided me with accurate and reliable data, which has greatly improved my workflow. I couldn't be happier with my experience!
I just started using Rdmd and I'm loving it! The interface is so user-friendly and intuitive. I can easily access and manage all my data with just a few clicks. The customer support team is also very helpful and responsive. I'm really happy with my experience so far!
Rdmd has exceeded my expectations. The platform is intuitive and easy to navigate, and their customer support team is top-notch. I had a few questions when I first started using Rdmd, and their team responded promptly and provided thorough answers. I'm really impressed with their service!
I'm really impressed with Rdmd. The platform is user-friendly, and the customer support team is always available to assist with any issues or questions. They provide accurate and reliable data, which has been incredibly helpful for my work. I highly recommend Rdmd to anyone in need of data management solutions!
Rdmd has been incredibly helpful in managing my data. The platform is user-friendly, and their customer support team is always responsive and helpful. I'm really impressed with the accuracy and reliability of the data they provide. I would definitely recommend Rdmd to others!
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
AllStripes is a Public Benefit Corporation on a mission to unlock new treatments for people affected by rare disease.
Rdmd: Unlocking New Treatments for Rare Diseases
Rdmd, formerly known as AllStripes, is a Public Benefit Corporation that is dedicated to unlocking new treatments for people affected by rare diseases. The company was founded in 2018 by Dr. Ethan Perlstein and Dr. Alex Sherman, who both have extensive experience in the field of rare disease research.
Rare diseases are defined as conditions that affect fewer than 200,000 people in the United States. Despite their rarity, there are over 7,000 different types of rare diseases that collectively affect an estimated 400 million people worldwide. Many of these conditions are genetic and can be life-threatening or severely debilitating.
One of the biggest challenges facing patients with rare diseases is the lack of effective treatments. Because these conditions are so uncommon, there is often little research into their underlying causes and potential therapies. This means that patients may go years without a diagnosis or effective treatment options.
Rdmd aims to change this by leveraging technology to accelerate rare disease research and drug development. The company has developed a platform called MyRARE™ that allows patients with rare diseases to share their medical data securely and anonymously with researchers around the world.
By aggregating this data from thousands of patients across hundreds of different rare diseases, Rdmd hopes to identify commonalities between these conditions and develop new therapies based on shared biological pathways or genetic mutations.
In addition to its patient-centric approach to research, Rdmd also partners with pharmaceutical companies and academic institutions to advance drug development programs for specific rare diseases. By combining its unique patient data resources with cutting-edge scientific expertise, Rdmd aims to bring new treatments to market faster than ever before.
One example of Rdmd's success in this area is its partnership with Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on developing therapies for serious ultra-rare genetic disorders. Together, Rdmd and Ultragenyx have launched a natural history study of patients with six different rare diseases, which will help inform the design of future clinical trials and accelerate the development of new treatments.
Rdmd's commitment to patient-centered research and collaboration has earned it recognition from both the scientific community and the business world. In 2020, the company was named one of Fast Company's Most Innovative Companies in Biotech, and it has also received funding from prominent venture capital firms such as Spark Capital and Lux Capital.
Overall, Rdmd is a pioneering company that is using technology to transform rare disease research and drug development. By empowering patients to share their data and collaborating with industry leaders, Rdmd is making significant strides towards unlocking new treatments for people affected by rare diseases.